du Bois, A;Sehouli, J;Lund, B;Joly, E;Huober, J;Jensen, TS;Levy, E;Heilmann, V;Boman, K;Hardy-Bessard, AC;Burges, A;Maenpaa, J;Pujade-Lauraine, E;Pfisterer, J;Gropp, M;Staehle, A;Wimberger, P;Jackisch, C;Schmalfeldt, B;Belau, A;Loibl, S;Wollschlaeger, K;Canzler, U;Rochon, J.Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) compari.Int J Gynecol Cancer.2005.15 Suppl..224-225